TNXB helps your body build strong connective tissue, the support material in skin and joints. The protein made by this gene helps your cells organize collagen so tissues stay resilient. When TNXB does not work well, some people develop a form of Ehlers-Danlos syndrome with loose joints, frequent sprains, chronic pain, and stretchy or fragile skin. In some families, TNXB changes occur with nearby adrenal gene changes and can be linked to hormone problems.
What is a gene?
A gene is a stretch of DNA that carries instructions your cells use to make molecules or to regulate activities in the body. In some cases, those instructions are used to produce proteins, which do much of the hands on work inside cells. In other cases, a gene’s main role is to help set when a process happens, where it takes place, and how strongly it is turned on. Taken together, genes affect how your body grows and operates, and they can also influence how you react to food, stress, or medications. For a deeper look at this subject, you can find more information in the LearnHub.
Overview
TNXBGene function
What if the gene works
The TNXB gene makes tenascin-X, a protein in connective tissues that helps organize collagen fibers. This supports skin firmness and joint stability and helps blood vessels and other tissues keep their shape.
Risk
What if the gene does not work
Changes in the TNXB gene can weaken connective tissue, leading to very flexible joints, frequent sprains or dislocations, stretchy skin, easy bruising, and ongoing pain. Effects can range from mild to more limiting, influencing which symptoms appear and when.
Treatment
What does that mean for your treatment
TNXB variants have no gene-targeted medicine, so care focuses on protecting joints and easing pain. Clinicians may modify physical therapy, bracing, and surgical decisions because connective tissue can be more fragile. Genetic results can help guide these choices.
Conditions associated with TNXB
Gene function
What if the gene works
Everyday movement and posture depend on connective tissues that are both strong and flexible, like skin, tendons, and joint coverings. TNXB supports this built-in “scaffolding” by helping shape the material around cells. Describing TNXB gene function is essentially describing how your body maintains sturdy, springy tissues over time.
The TNXB gene helps your body build and maintain the supportive framework around cells, called the extracellular matrix (the material that holds tissues together). This framework helps tissues keep their shape during routine stretching and movement.
The TNXB gene supports the orderly arrangement of collagen fibers, which are a major source of strength in connective tissue. Well-organized collagen helps tissues handle pulling and bending in a more controlled way.
Through its protein, the TNXB gene helps tissues balance firmness with flexibility. This matters in places that regularly stretch and rebound, such as skin and many soft tissues around joints.
TNXB contributes to “landing pads” and signals that help cells attach to their surroundings. This supports normal tissue upkeep, as cells respond to the structure and spacing of the matrix around them.
What is a variant?
A genetic variant is a minor difference in the DNA sequence within a gene. These changes are widespread and help explain normal differences between people, such as variation in appearance, metabolism, or the way the body reacts to environmental factors. Many variants do not cause any obvious effects and are part of typical genetic diversity. In certain situations, though, a variant can more strongly affect how a gene works and may play a role in, or lead to, a genetic condition.
Genetic variants
What if the gene does not work
Changes in the TNXB gene can affect the body’s connective tissue, which can show up as loose joints, stretchy skin, easy bruising, or chronic aches. Many TNXB gene variants reduce the amount or change the shape of tenascin-X, a support protein in tendons, ligaments, and skin. DNA changes range from milder variants to severe TNXB gene mutation patterns, and this spectrum can influence when symptoms start and how broad they are, including TNXB gene variants linked to classical-like Ehlers-Danlos syndrome.
How variants are linked to conditions
Changes in the TNXB gene are best known for causing classic-like Ehlers-Danlos syndrome, a connective tissue condition that can be confirmed when a person has two disease-causing TNXB variants. Studies also link certain TNXB changes to CAH-X syndrome, where congenital adrenal hyperplasia occurs alongside Ehlers-Danlos–type features due to a combined genetic change in this region. Research on TNXB gene variants and Ehlers-Danlos syndrome also suggests some single-copy changes may be associated with joint hypermobility in some families, but this is less consistent.
A variant is not necessarily a diagnosis
Genetic variants are a routine feature of human biology, and many people in the general population have them. Most variants do not directly affect health and instead represent ordinary human diversity. For many genes, having a variant that has been linked to a condition signals a potential association rather than a certain diagnosis, particularly when several genes and environmental influences contribute. In some situations, though, one well-studied variant in a particular gene can be enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For conditions linked to changes in the TNXB gene, day-to-day choices do not meaningfully change whether you have the condition, because the gene change is the main driver. Risk of problems like joint injuries, long-lasting pain, and skin tears can increase with high-impact sports, heavy lifting, and repeated strains. Gentle strengthening, joint protection, and regular follow-up for new or worsening symptoms can help prevent complications.
Inheritance of TNXB variants
Most health conditions linked to changes in the TNXB gene follow an autosomal recessive TNXB inheritance pattern, meaning a person typically needs to inherit a changed copy from both parents to be affected. Parents who each carry one changed copy usually have a 1 in 4 (25%) chance in each pregnancy of having an affected child, and a 1 in 2 (50%) chance of having a child who is a carrier. This can be passed on by any parent to children of any sex.
What does my TNXB result mean for my family?
Seek medical advice if a TNXB result is linked to very flexible joints, frequent sprains or dislocations, ongoing pain, easy bruising, or stretchy or fragile skin, especially when several relatives have similar issues. Ask for guidance before surgery, dental work, or pregnancy, since tissue fragility can affect care. Get urgent help for sudden severe chest or belly pain or fainting.
Genetic information
Genetic testing
How you find out about variants
A blood or saliva sample can be analyzed in a lab to look for changes through TNXB genetic testing for variants. The lab reads the gene’s DNA sequence and checks for missing, extra, or altered pieces compared with a typical reference, then reports any variants found and what they may mean for you and your family.
When should I consider getting a genetic test?
Consider genetic testing for the TNXB gene if you or a close relative has signs of a connective tissue condition, such as very loose joints with frequent sprains or dislocations, unusually stretchy skin, easy bruising, or slow wound healing. Testing can also be helpful when these features run in families or when a doctor suspects a specific inherited cause.
A genetic result is only one part of your health story
Genetic test results can be very informative, but what they mean depends on the specific condition and the kind of genetic variant found. How your body functions over time is also shaped by factors like lifestyle, environment, age, and your medical history. With some conditions, particularly those affected by many genes, genetic information provides helpful context rather than a definite prediction and makes the most sense when considered with other parts of your care. In other situations, the result can be more straightforward and give a clear explanation. For topics like how someone responds to medications, genetic findings can help put personal experiences into perspective.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines, because genes influence how the body absorbs, breaks down, transports, or reacts to a drug. The TNXB gene mainly helps support connective tissue (the body’s “scaffolding”) and is not typically used to guide medication choice in routine pharmacogenetic care. Even so, many common gene differences across the genome can mean the same dose feels very effective for one person, barely helps another, or causes more side effects. This is one reason medication response varies from person to person, and genetic results are only one piece of the bigger health picture.
What is Pharmacogenetics?
Pharmacogenetics examines how differences in your genes can shape the way you respond to medicines. It focuses on links between specific genes and specific drugs to explain why the same treatment can have different effects in different people. For a wide range of medications, genetics may affect how powerfully a drug works or how your body breaks it down. Understanding these relationships can support more informed choices and more personalized treatment decisions. More information on this subject is available in the LearnHub.
Drugs influenced by the TNXB gene
When should I seek medical advice?
Seek medical advice if you have frequent joint dislocations or sprains, long-lasting pain, unusually stretchy skin, or easy bruising that affects life. Get urgent care for sudden chest pain, shortness of breath, or fainting. If you know you have a TNXB-related condition, tell your clinician before surgery, dental work, pregnancy care, or starting a new exercise or physical therapy plan.
History
The TNXB gene entered medical genetics in the 1990s, when researchers identified tenascin-X as part of a family of connective tissue proteins and mapped its gene in the complex HLA region on chromosome 6. In recent decades, awareness of this gene’s role has grown. In the early 2000s, studies connected certain TNXB changes to a form of Ehlers-Danlos syndrome marked by joint looseness and stretchy skin. Later work clarified that TNXB can be involved in “contiguous gene” findings next to the CYP21A2 gene, helping explain why some people with congenital adrenal hyperplasia also have Ehlers-Danlos–like features, a pattern often called CAH-X.